Validea's Multi-Factor Investor model, based on Pim van Vliet's low-volatility, momentum, and net payout yield strategy, rates STRYKER CORP (SYK) at 75%. While SYK, a large-cap medical equipment stock, passes market capitalization and standard deviation criteria, it shows neutral performance on momentum and net payout yield, ultimately failing the final rank and falling below the 80% threshold typically indicating investment interest from this quantitative framework.
According to Validea's guru fundamental report, Stryker Corp (SYK) receives a score of 75% from the Multi-Factor Investor model, which is based on Pim van Vliet's strategy favoring low volatility, strong momentum, and high net payout yields. This score falls below the 80% threshold that typically indicates investment interest from the model. While SYK, a large-cap medical equipment stock, successfully passes the criteria for market capitalization and standard deviation, reflecting its low-volatility characteristics, its performance is only 'Neutral' on the 'Twelve Minus One Momentum' and 'Net Payout Yield' factors. Consequently, the stock receives a 'FAIL' on its 'FINAL RANK' within this specific quantitative framework, suggesting that despite its stability, it currently lacks the combined momentum and shareholder return profile sought by this conservative factor strategy.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately negative
Sentiment Score
-0.30
Ticker Sentiment
